Many patients with Paget's disease of bone experience symptoms or complications related to the exuberant bone resorptive activity that characterizes this disease. Medical therapy now provides symptomatic benefit for many patients. As more effective pharmacologie agents become available in the near future, the possibilities of preventing the complications and inducing complete and perhaps permanent remission of this disorder will become reasonable therapeutic objectives.